SharkNinja recalls 1.8 million pressure cookers due to reports of second- and third-degree burns
SharkNinja is recalling 1.8 million pressure cookers due to 106 reports of burn injuries that have sparked more than two dozen lawsuits against the company, the Consumer Product Safety Commission said Thursday.
About 50 of the reports cited second- or third-degree burns to consumers' faces or bodies, the statement said. Third-degree burns, the most serious burn level, destroy the epidermis and dermis, or the outer and middle layers of skin, and can also damage a person's bones, muscles and tendons, according to Johns Hopkins Medicine.
The pressure cooker's lid can be opened while in use, allowing hot contents to escape, posing a burn risk to consumers, the recall notice said.
Which pressure cooker is under recall?
The recall covers the SharkNinja Foodi OP300 Series Multi-Function Pressure Cooker. The company is recalling 1.85 million of the devices in the U.S., as well as about 184,000 sold in Canada.
The cookers, which can also air fry, were sold in black and have a 6.5-quarter capacity.
The following model numbers are part of the recall:
OP300
OP301
OP301A
OP302
OP302BRN
OP302HCN
OP302HAQ
OP302HW
OP302HB
OP305
OP305CO
OP350CO
The model numbers are printed on a label on the side of the cooker.
Also included in the recall are OP300 series replacement pressure cooker lids purchased as an extra part, the statement said.
Where was the SharkNinja device sold?
The device, made by by Needham, Massachusetts-based SharkNinja, was sold at Walmart, Costco, Sam's Club, Amazon and Target stores across the U.S.
The pressure cooker was also available online at www.Ninjakitchen.com, www.walmart.com, www.costco.com, www.samsclub.com, www.amazon.com and www.target.com.
The device was sold from January 2019 through March 2025 and cost about $200.
What should consumers do?
People who own the devices should immediately stop using them and contact SharkNinja for a free replacement lid, the CPSC said.
"Consumers can continue to use the product's air frying and other functions," the recall notice added.
Owners of the devices can contact SharkNinja at 888-370-1733 from 9 a.m. to 9 p.m. EST, Monday through Friday, and 9 a.m. to 6 p.m. EST on Saturday.
They can also email the company at sharkninja@rqa-inc.com, or visit its website at https://www.rqa-inc.com/client/SharkNinja/ or www.ninjakitchen.com and click on "Recalls" under "Support" at the top of the page.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
3 hours ago
- Boston Globe
Will Trump's policies kill Massachusetts' life sciences leadership?
Advertisement Although the industry is centered in eastern Massachusetts, there's a statewide benefit from all the tax dollars those businesses and workers pay. Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up In all, Massachusetts organizations — including universities, research institutes, and hospitals — received $3.5 billion in funding from the National Institutes of Health. Massachusetts-headquartered companies raised $3.26 billion in venture capital funding. Among all drugs in the development pipeline in the United States, 15 percent were being made by companies headquartered in Massachusetts. But actions taken by President Trump and his administration — cutting funding for scientific research and universities, flirting with tariffs, fanning skepticism about vaccines — threaten to devastate the ecosystem. Today, the industry is at a precipice, and uncertainty abounds. Some companies are already feeling the pinch of terminated federal grants, while others are anxious about what might come. Taken together, Trump's policies could force some companies and scientists to take their money, talents, and products overseas. Advertisement Christopher Locher, CEO of Lowell-based Versatope Therapeutics, which develops a platform to deliver vaccines and therapeutics, said he worries the Greater Boston life sciences ecosystem is 'being flushed down the toilet.' For example, Trump is Trump's funding cuts are already having a large impact on some local companies. Part of the problem is the Trump administration isn't only cutting funding, but it's picking which technologies to fund — in some cases apparently based on politics more than science. Take flu vaccines. The Trump administration recently announced a $500 million campaign to fund the development of a universal flu vaccine, which doesn't require annual updates, using technology being worked on But simultaneously, he cut funding for other work on a universal flu vaccine. Versatope Therapeutics got $14 million in NIH funding and spent five years developing a universal flu vaccine. It had approval from the US Food and Drug Administration to begin clinical trials when Trump terminated the contract's remaining $8 million, with the reason given being 'convenience,' Locher said. Trump also Advertisement Company executives say decisions by Trump officials to disinvest in vaccine-related technology — and concerns about whether government will approve new technology — means it's nearly impossible to find private investment funding to replace lost federal dollars. 'We're faced with bankruptcy in the very near future,' Locher said. Ironically, given Trump's stated commitment to bringing businesses back to the United States, one potential option Locher is eyeing is opening a subsidiary abroad. Conducting clinical trials would be cheaper in another country, whether in Europe, Australia, or China, Locher said, and some countries are offering financial incentives to American companies to relocate. Companies also face a potential workforce brain drain. There have been MassBio officials said China has less rigorous — but faster — safety and research protocols than the US. Australia allows a faster timeline for clinical trials. If regulatory approval of medicines is held up because the FDA is understaffed, companies may seek European regulatory approval instead. The loss of talent to foreign countries will be compounded if the pipeline of local university graduates dries up. One draw for life sciences companies to Boston/Cambridge is the presence of elite schools like Harvard and MIT, with their potential for faculty collaboration and skilled graduates. Advertisement Trump is trying to Chip Clark, CEO at Vibrant Biomedicines in Cambridge, said cuts to university research funding both 'shrink the pipeline of great ideas' that form the basis for many biotech startups and translate to fewer available scientists. Clark said the administration's policies 'seem like a deliberate attempt to try to cede scientific leadership to Europe and Japan and Korea and China. ... They will be delighted to capitalize on our talent, technology, and investment capital to make their robust biotech sectors grow and ultimately compete successfully against the US industry,' he said. Don Ingber, founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, said he has postdocs with US visas applying for jobs in Europe, and others who were accepted to work at Harvard but are going elsewhere. 'The fact that places like Harvard and MIT and American universities are magnets for the best and brightest from around the world is what's driven our technology economy and certainly the Boston/Cambridge ecosystem,' Ingber said. 'With this uncertainty, I fear we'll lose a generation.' Ingber, who was forced to stop work on two government-funded projects on drugs designed to prevent injury from radiation exposure, compared administration policies to 'eating seed corn' needed to grow crops. Advertisement Trump's vendetta will undermine one of the most vibrant state economies in the country and set back American science by years. And it's not just eastern Massachusetts that will pay a price; the entire country will. As Ingber noted, it might take years to see the impact of medicines or technologies that aren't developed because of these shortsighted cuts. Editorials represent the views of the Boston Globe Editorial Board. Follow us
CBS News
8 hours ago
- CBS News
Botulism cases from Botox injections linked to Milton spa, health officials say
The Massachusetts Department of Public Health (DPH) has linked a Milton spa to a string of botulism cases from Botox injections. Ten people are suspected to have iatrogenic botulism, a rare but serious illness, after receiving a procedure at Rodrigo Beauty on Granite Avenue. Health officials advise that anyone who received Botox injections between May 1 and June 4 should contact their nearby health department or DPH. Iatrogenic botulism can happen when Botox spreads beyond where it was injected. Symptoms of iatrogenic botulism include blurred or double vision, slurred speech, breathing difficulties, drooping eyelids, and difficulty swallowing. Some more serious cases may experience progressive muscle weakness. If you experience any of these symptoms, the DPH recommends visiting the nearest emergency room. "Early recognition and treatment can significantly improve outcomes," the DPH said in a statement. The DPH asks that anyone contact them with questions or concerns at 617-983-6800. What is Botox? Cosmetic botulinum toxin, commonly referred to as Botox injections, is a "purified substance derived from bacteria," according to the American Society of Plastic Surgeons. It blocks the nerve signal to the muscle, which prevents the muscle from moving. It is commonly used to prevent wrinkles in the face. The Massachusetts DPH emphasizes that trained professionals should inject Botox and that the technique, use of non-FDA-approved products, and improper dosing increase the risk of botulism. Massachusetts spa owner arrested A Stoughton spa owner, with locations in Easton and Randolph, was arrested in November of 2024 for allegedly using illegal counterfeit Botox and filler injections. Thirty-eight-year-old Rebecca Fadanello allegedly performed thousands of injections using imported Botox, Sculptra, and Juvederm from China and Brazil. She purchased the products from Alibaba, a Chinese company that claims to sell products in bulk. She was charged with one count of illegally importing merchandise contrary to law, one count of selling or dispensing a counterfeit drug, and one count of selling or dispensing a counterfeit device.
Yahoo
11 hours ago
- Yahoo
10 botulism cases linked back to Milton spa, health officials say
The Massachusetts Department of Health (DPH) has issued a warning to the public after an increase in botulism cases has been linked to a spa in Milton. Officials say that the suspected cases are tied back to Rodrigo Beauty, located at 464 Granite Ave, in Milton. As of today, at least 10 people have been linked to the suspected iatrogenic botulism. In a statement from the DPH, iatrogenic botulism is a 'rare but serious illness caused by botulinum toxin spreading beyond the injection site, potentially leading to life-threatening symptoms.' On Thursday, the DPH released a statement about an investigation into 4 cosmetic botulism cases on the South Shore. First and early symptoms include: blurred or double vision, drooping eyelids, slurred speech, difficulty swallowing, or breathing difficulties. The DPH is advising anyone who has received Botox injections from the Milton spa between May 1 and June 4 is strongly urged to contact the Massachusetts Department of Public Health at 617-983-6800 or their local board of health immediately, even if they are not currently experiencing symptoms. The DPH also reiterated the importance of undergoing a procedure like Botox injections from a licensed professional with medical credentials. This is a developing story. Check back for updates as more information becomes available. Download the FREE Boston 25 News app for breaking news alerts. Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW
